Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
3.650
+0.040 (1.11%)
At close: Mar 9, 2026, 4:00 PM EDT
3.690
+0.040 (1.10%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $8.15 million as of March 9, 2026. Its market cap has increased by 213.31% in one year.
Market Cap
8.15M
Enterprise Value
6.21M
1-Year Change
213.31%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $8.15M, a decrease of -89.32%. That is a compound annual growth rate of -10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.10M | 12.50% |
| Dec 31, 2025 | 7.20M | 132.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 8.74M |
| CollPlant Biotechnologies | 8.73M |
| Theriva Biologics | 8.29M |
| Bolt Biotherapeutics | 8.25M |
| PharmaCyte Biotech | 8.08M |
| KALA BIO | 7.86M |
| Ernexa Therapeutics | 7.72M |
| Alzamend Neuro | 7.53M |